These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 3705676

  • 1. [Clinical studies with prednicarbate with special reference to double-blind comparisons with common therapeutic preparations].
    Schröpl F.
    Z Hautkr; 1986; 61 Suppl 1():80-7. PubMed ID: 3705676
    [Abstract] [Full Text] [Related]

  • 2. [Photographic follow-up of the topical use of prednicarbate preparations in inflammatory dermatoses].
    Schulz H.
    Z Hautkr; 1986; 61 Suppl 1():51-61. PubMed ID: 3705673
    [Abstract] [Full Text] [Related]

  • 3. [Topical use of prednicarbate preparations in children].
    Schulz H, Maue R, Meyer-Latzke E.
    Z Hautkr; 1986; 61 Suppl 1():41-50. PubMed ID: 2939635
    [Abstract] [Full Text] [Related]

  • 4. [Reaction of autogenous cortisol production in patients with extensive psoriasis vulgaris or atopic dermatitis following external administration of a 0.25% prednicarbate salve (W/O emulsion)].
    Ernst TM.
    Z Hautkr; 1986; 61 Suppl 1():74-9. PubMed ID: 3010589
    [Abstract] [Full Text] [Related]

  • 5. Halcinonide, a new topical anti-inflammatory steroid.
    Savin RC.
    J Int Med Res; 1976; 4(1):34-6. PubMed ID: 799976
    [Abstract] [Full Text] [Related]

  • 6. [The Berlin Model. A multicenter study of prednicarbate in various vehicles].
    Albrecht G.
    Z Hautkr; 1986; 61 Suppl 1():88-96. PubMed ID: 2939636
    [Abstract] [Full Text] [Related]

  • 7. [Animal experiment studies on the topical and systemic effectiveness of prednisolone-17-ethylcarbonate-21-propionate].
    Alpermann HG, Sandow J, Vogel HG.
    Z Hautkr; 1986; 61 Suppl 1():7-17. PubMed ID: 3705675
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Topical glucocorticoids with improved benefit/risk ratio: do they exist?
    Korting HC, Kerscher MJ, Schäfer-Korting M.
    J Am Acad Dermatol; 1992 Jul; 27(1):87-92. PubMed ID: 1619082
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical test with Apolar cream and Calmuril-hydrocortisone cream in contact dermatitis and atopic dermatitis].
    Gip L.
    Tidsskr Nor Laegeforen; 1978 Apr 10; 98(10):509-10. PubMed ID: 354085
    [No Abstract] [Full Text] [Related]

  • 19. 0.25% prednicarbate cream and the corresponding vehicle induce less skin atrophy than 0.1% betamethasone-17-valerate cream and 0.05% clobetasol-17-propionate cream.
    Korting HC, Vieluf D, Kerscher M.
    Eur J Clin Pharmacol; 1992 Apr 10; 42(2):159-61. PubMed ID: 1618247
    [Abstract] [Full Text] [Related]

  • 20. Clobetasone butyrate compared with betamethasone valerate in the treatment of atopic and contact dermatitis.
    Fredriksson T, Nordin K.
    Curr Med Res Opin; 1979 Apr 10; 6(5):322-4. PubMed ID: 540522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.